Trials / Recruiting
RecruitingNCT06272045
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6,618 (estimated)
- Sponsor
- JHSPH Center for Clinical Trials · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH) is a cluster randomized clinical trial, funded by the National Heart Lung \& Blood Institute. The study is designed to test the effectiveness of home visiting intervention to promote cardiovascular health and reduce disparities in maternal and early childhood cardiovascular health. Sites, in partnership with evidence-based home visiting programs, are recruiting 6618 participants in total (i.e., 3309 mother-child dyads which includes 3309 mothers and 3309 children) from diverse community settings with a high burden of cardiovascular disease risk factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | ENRICH | In the ENRICH intervention, home visitors will incorporate heart health information and activities into routine home visits beginning in pregnancy and continuing until children turn 2 years old. The intervention includes 1) Information and resources on topics such as healthy eating, physical activity, weight management, tobacco use, healthy sleep and stress reduction, 2) tools like scales, Fitbits, and blood pressure monitors to facilitate self-monitoring, and 3) activities and information focused on infant nutrition, feeding, healthy growth, sleep, play and emotions and soothing. |
| BEHAVIORAL | Usual Home Visiting | Usual home visiting without cardiovascular health promotion content |
Timeline
- Start date
- 2024-06-19
- Primary completion
- 2028-03-30
- Completion
- 2029-03-30
- First posted
- 2024-02-22
- Last updated
- 2026-04-13
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT06272045. Inclusion in this directory is not an endorsement.